On Jul. 6, 2020, Regeneron announced initiation of late-stage clinical trials evaluating REGN-COV2, Regeneron’s investigational double antibody cocktail…
On Jul. 6, 2020, Meridian HSN announced it had partnered with Moto-Para and Todos Medical to provide a…
On Jul. 6, 2020, Mylan announced that the Drug Controller General of India (DCGI) has approved its remdesivir…
On Jul. 4, 2020, the World Health Organization (WHO) accepted the recommendation from the Solidarity Trial’s International Steering…
On Jul. 3, 2020, Gilead Sciences announced the European Commission had granted conditional marketing authorization for Vekluryﾮ (remdesivir)…
On Jul. 3, 2020, CytoDyn announced it had signed an exclusive Distribution and Supply Agreement with American Regent…
On Jul. 2, 2020, Abivax announced that the first patient has been treated in its Phase 2b/3 study…
On Jul. 2, 2020, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for…
On Jul. 2, 2020, Royal Philips announced that the FDA had issued an Emergency Use Authorization (EUA) for…
On Jul. 2, 2020, in response to the continuing need for more COVID-19 diagnostic tests, the Translational Genomics…
On Jul. 2, 2020, scientists from Duke University, Los Alamos National Laboratory and La Jolla Institute for Immunology…
On Jul. 2, 2020, UConn announced a licensing deal with Connecticut Biotech, a startup company headquartered in South…
On Jul. 2, 2020, Regeneron and Sanofi announced that the U.S. Phase 3 trial of Kevzara (sarilumab) 400…
On Jul. 2, 2020, Ceres Nanosciences and its collaborators at George Mason University announced they had have developed…
On Jul. 1, 2020, in a Perspective for the New England Journal of Medicine, members of the NIHﾒs…
On Jul. 1, 2020, FUJIFILM announced a partnership with Dr. Reddy’s Laboratories, a global pharmaceutical company headquartered in…
On Jul. 1, 2020, MediciNova announced that the Investigational New Drug Application (IND) for MN-166 (ibudilast) for prevention…
On Jul. 1, 2020, Merck and and and Ridgeback Biotherapeutics announced that the U.S. Federal Trade Commission (FTC)…
On Jul. 1, 2020, T2 Biosystems announced completion of validation of its COVID-19 molecular diagnostic test, the T2SARS-CoV-2…
On Jul. 1, 2020, OPKO Health announced the results of COVID-19 molecular PCR and antibody tests for nursing…
On Jul. 1, 2020, InBios announced that it had received Emergency Use Authorization (EUA) from the FDA for…
On Jun. 30, 2020, scientists from the Innovative Genomics Institute (IGI) at the University of California Berkeley announced…
On Jun. 29, 2020, the U.S. Dept. of Veterans Affairs (VA) announced it had launched a digital COVID-19…
On Jun. 29, 2020, the University of Oxford reported that potential COVID-19 hotspots can be identified using a…
On Jun. 29, 2020, Bharat Biotech announced it had successfully developed COVAXIN, India’s 1st vaccine candidate for COVID-19,…
On Jun. 29, 2020, JAMA reported that U.S. populationﾖbased time series analysis conducted between March 9, 2020, and…
On Jun. 29, 2020, the Michael Smith Foundation for Health Research (MSFHR) COVID-19 Research Response Fund announced funding…
On Jun. 29, 2020, Altimmune announced it was awarded $4.7 million from the U.S. Army Medical Research &…
On Jun. 29, 2020, LabCorpﾮ announced that Covance, its drug development business, has deployed the Xcellerateﾮ COVID-19 solution…
On Jun. 29, 2020, Todos Medical announced that it had entered into a partnership with Meridian Health Services…